Predicting response to pegylated interferon/ribavirin-based therapy in genotype 1 chronic hepatitis C patients: results of 3 independent genome-wide association studies

Gastroenterology. 2010 Apr;138(4):1622-4. doi: 10.1053/j.gastro.2010.02.023. Epub 2010 Feb 21.

Authors

Sumeet K Asrani¹, W Ray Kim

Affiliation

¹ Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

PMID: 20175968
DOI: 10.1053/j.gastro.2010.02.023

No abstract available

Publication types

Comment